Cargando…

Low-Dose Interleukin-2 Therapy: A Driver of an Imbalance between Immune Tolerance and Autoimmunity

For many years, the role of interleukin-2 (IL-2) in autoimmune responses was established as a cytokine possessing strong pro-inflammatory activity. Studies of the past few years have changed our knowledge on IL-2 in autoimmune chronic inflammation, suggesting its protective role, when administered a...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kosmaczewska, Agata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227233/ https://www.ncbi.nlm.nih.gov/pubmed/25322151 http://dx.doi.org/10.3390/ijms151018574

Ejemplares similares

Retrospective analysis of low-dose interleukin-2 therapy on chronic autoimmune thyroid disease with concurrent systemic lupus erythematosus
por: Wang, Naidi, et al.
Publicado: (2023)

Identification of the correlations between interleukin-27 (IL-27) and immune-inflammatory imbalance in preterm birth
por: Ran, Yuxin, et al.
Publicado: (2021)

Low-dose interleukin-2 therapy in systemic lupus erythematosus
por: La Cava, Antonio
Publicado: (2023)

Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
por: Graßhoff, Hanna, et al.
Publicado: (2021)

Imbalance in PB IL-17-Secreting and Regulatory Cells in Pars Planitis Is Associated with Dysregulation of IFN-γ-Secreting Cells, Especially in Patients with Clinical Complications
por: Kosmaczewska, Agata, et al.
Publicado: (2020)

Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
por: Zhang, Xia, et al.
Publicado: (2021)

Chromosome Imbalance as a Driver of Sex Disparity in Disease
por: Abramowitz, Lara K., et al.
Publicado: (2014)

Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa
por: Esposito, Susanna, et al.
Publicado: (2016)

Sustained low‐dose interleukin‐2 therapy alleviates pathogenic humoral immunity via elevating the Tfr/Tfh ratio in lupus
por: Liang, Kaili, et al.
Publicado: (2021)

Low‐dose interleukin‐2 promotes STAT‐5 phosphorylation, T(reg) survival and CTLA‐4‐dependent function in autoimmune liver diseases
por: Jeffery, H. C., et al.
Publicado: (2017)

Interleukin-18 Binding Protein in Immune Regulation and Autoimmune Diseases
por: Park, Seung Yong, et al.
Publicado: (2022)

Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia
por: Han, Panpan, et al.
Publicado: (2021)

Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia
por: Liu, Zongtang, et al.
Publicado: (2016)

Risky Driver Recognition with Class Imbalance Data and Automated Machine Learning Framework
por: Wang, Ke, et al.
Publicado: (2021)

Immune tolerance: DNA vaccine as strategy in autoimmune diseases
por: Saiah, I Djilali
Publicado: (2004)

Immune Tolerance in Autoimmune Central Nervous System Disorders
por: Jayaraman, Sundararajan, et al.
Publicado: (2019)

Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Requires Interleukin 27 Signaling in Dendritic Cells
por: Thomé, Rodolfo, et al.
Publicado: (2017)

Therapeutic Window of Interleukin-2 for Autoimmune Diseases
por: Tang, Qizhi
Publicado: (2015)

Chemokine/Interleukin Imbalance Aggravates the Pathology of Respiratory Syncytial Virus Infection
por: Mori, Kentaro, et al.
Publicado: (2022)

Astrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity
por: Jukkola, Peter, et al.
Publicado: (2013)

Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
por: Mukherjee, Manali, et al.
Publicado: (2017)

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
por: Ellebaek, Eva, et al.
Publicado: (2012)

Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19
por: Philippe, Aurélien, et al.
Publicado: (2022)

Genetic basis of defects in immune tolerance underlying the development of autoimmunity
por: Hocking, Anne M., et al.
Publicado: (2022)

Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance
por: Zhang, Zinan, et al.
Publicado: (2019)

Exogenous IL-2 Controls the Balance in Th1, Th17, and Treg Cell Distribution in Patients with Progressive Rheumatoid Arthritis Treated with TNF-Alpha Inhibitors
por: Kosmaczewska, Agata, et al.
Publicado: (2014)

Immune imbalance is associated with the development of preeclampsia
por: Ma, Yu, et al.
Publicado: (2019)

Transglutaminases in Dysbiosis As Potential Environmental Drivers of Autoimmunity
por: Lerner, Aaron, et al.
Publicado: (2017)

Low‐dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success
por: Elalfy, Mohsen, et al.
Publicado: (2021)

Electrotransfer of low doses of plasmid encoding interleukin-10 in gene therapy of collagen-induced arthritis
por: Boissier, Mc
Publicado: (2002)

Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model
por: Wang, Yifan, et al.
Publicado: (2022)

Low Dose Rapamycin Exacerbates Autoimmune Experimental Uveitis
por: Zhang, Zili, et al.
Publicado: (2012)

Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming
por: Aso, Kuniyuki, et al.
Publicado: (2023)

Interleukin-12p35 Deficiency Reverses the Th1/Th2 Imbalance, Aggravates the Th17/Treg Imbalance, and Ameliorates Atherosclerosis in ApoE-/- Mice
por: Huang, Ying, et al.
Publicado: (2019)

Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody
por: Ciszak, Lidia, et al.
Publicado: (2015)

CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia
por: Ciszak, Lidia, et al.
Publicado: (2015)

Is Tolerance Broken in Autoimmunity?
por: Laxminarayana, Dama
Publicado: (2017)

Tolerance and autoimmunity in the liver
por: Schramm, Christoph, et al.
Publicado: (2022)

OR18-05 Interleukin 21 Drives The Development Of Autoimmune Diabetes Mellitus During Immune Checkpoint Inhibitor Cancer Therapy
por: Garcia Ortega, Jessica Rachel, et al.
Publicado: (2023)

Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome
por: Parisi, Valentina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7eipe7oi416os4o55gu1l87c26